Rockwell Medical P/E 2024

Rockwell Medical Aktienanalyse

What does Rockwell Medical do?

Rockwell Medical Inc. is a medical technology company based in Wixom, Michigan. Established in 1995 by Robert L. Chioini and Thomas E. Klema, the company specializes in the development and marketing of innovative therapies for patients with kidney failure. The history of Rockwell Medical began with the development of "dialysate concentrate" which aimed to reduce the risk of side effects in dialysis patients. After receiving approval from the US Food and Drug Administration in 2000, the company began marketing this product. In the following years, Rockwell Medical expanded its product range and developed new therapies for patients with kidney failure. Today, the company is a leading provider of dialysis products in the US and offers a wide range of therapies tailored to the specific needs of dialysis patients. Rockwell Medical's business model is based on the development and marketing of innovative therapies for patients with kidney failure. The company collaborates closely with nephrologists and dialysis centers to optimize its products for the needs of patients. Rockwell Medical's products are sold both directly to dialysis centers and to wholesalers. An important area of Rockwell Medical's activities is the development of therapies for the treatment of dialysis-related conditions such as anemia and mineral imbalances. This includes, for example, the iron preparation Triferic, which is used to treat anemia in dialysis patients. Triferic is administered via the dialysate during dialysis to ensure optimal iron supply to the body. Another important product of Rockwell Medical is Calcitriol, a hormone used to treat mineral imbalances in dialysis patients. Mineral imbalances can occur with insufficient kidney function and can lead to bone changes and heart disease. Calcitriol helps to treat these imbalances and reduce the risk of complications. In addition to dialysis products and therapies, Rockwell Medical also offers a range of products for the treatment of patients with serious illnesses such as cancer or HIV. These include sodium chloride solutions and infusion pumps. Rockwell Medical places great emphasis on the quality and safety of its products. The company has its own research and development center and works closely with leading medical experts to continuously develop its products and keep up with the latest scientific advancements. In summary, Rockwell Medical is an innovative medical technology company specializing in the development and marketing of therapies for patients with kidney failure. The company offers a wide range of dialysis products and therapies and collaborates closely with nephrologists and dialysis centers to meet the needs of its patients. Rockwell Medical has established itself as a leading provider of dialysis products in the US and is continuously committed to researching and developing new therapies. Rockwell Medical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Rockwell Medical's P/E Ratio

The Price to Earnings (P/E) Ratio of Rockwell Medical is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Rockwell Medical's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Rockwell Medical is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Rockwell Medical’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Rockwell Medical stock

What is the price-to-earnings ratio of Rockwell Medical?

The price-earnings ratio of Rockwell Medical is currently -43.99.

How has the price-earnings ratio of Rockwell Medical changed compared to last year?

The price-to-earnings ratio of Rockwell Medical has increased by 329.17% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Rockwell Medical high compared to other companies?

Yes, the price-to-earnings ratio of Rockwell Medical is high compared to other companies.

How does an increase in the price-earnings ratio of Rockwell Medical affect the company?

An increase in the price-earnings ratio of Rockwell Medical would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Rockwell Medical affect the company?

A decrease in the price-earnings ratio of Rockwell Medical would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Rockwell Medical?

Some factors that influence the price-earnings ratio of Rockwell Medical are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Rockwell Medical pay?

Over the past 12 months, Rockwell Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Rockwell Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of Rockwell Medical?

The current dividend yield of Rockwell Medical is .

When does Rockwell Medical pay dividends?

Rockwell Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Rockwell Medical?

Rockwell Medical paid dividends every year for the past 0 years.

What is the dividend of Rockwell Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Rockwell Medical located?

Rockwell Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Rockwell Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Rockwell Medical from 11/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/3/2024.

When did Rockwell Medical pay the last dividend?

The last dividend was paid out on 11/3/2024.

What was the dividend of Rockwell Medical in the year 2023?

In the year 2023, Rockwell Medical distributed 0 USD as dividends.

In which currency does Rockwell Medical pay out the dividend?

The dividends of Rockwell Medical are distributed in USD.